Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Change in Cash (2023 - 2025)

Historic Change in Cash for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $71.6 million.

  • Zenas BioPharma's Change in Cash fell 5936.66% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$244.6 million, marking a year-over-year decrease of 18499.7%. This contributed to the annual value of $262.9 million for FY2024, which is 263949.96% up from last year.
  • Zenas BioPharma's Change in Cash amounted to $71.6 million in Q3 2025, which was down 5936.66% from -$152.5 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Change in Cash registered a high of $176.1 million during Q3 2024, and its lowest value of -$152.5 million during Q2 2025.
  • Over the past 3 years, Zenas BioPharma's median Change in Cash value was -$17.6 million (recorded in 2023), while the average stood at $5.4 million.
  • Within the past 5 years, the most significant YoY rise in Zenas BioPharma's Change in Cash was 5936.66% (2025), while the steepest drop was 52571.31% (2025).
  • Over the past 3 years, Zenas BioPharma's Change in Cash (Quarter) stood at -$15.5 million in 2023, then plummeted by 160.74% to -$40.3 million in 2024, then soared by 277.59% to $71.6 million in 2025.
  • Its last three reported values are $71.6 million in Q3 2025, -$152.5 million for Q2 2025, and -$123.3 million during Q1 2025.